BSX Financial Facts

Gain on divestiture: 0
Net income (loss) per common share - assuming dilution: 0.03
See Full Income Statement

See Full Balance Sheet

Boston Scientific (BSX) Earnings

  |   Expand Research on BSX
Next EPS Date 7/24/15 *Est. EPS Growth Rate +5.0% *Last Qtr.
Average EPS % Beat Rate -0.1% Revenue Growth Rate 0.0% *Last Qtr.
Average % Move 1-Wk after EPS +2.5% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/28/15 Q115 $0.21$0.21 $0.00$1.77B$1.78B = Details
2/4/15 Q414 $0.22$0.21 +$0.01$1.89B$1.91B = Details
10/22/14 Q314 $0.20$0.20 $0.00$1.85B$1.82B Details
7/24/14 Q214 $0.18$0.19 -$0.01$1.87B$1.87B Details
4/29/14 Q114 $0.20$0.18 +$0.02$1.77B$1.8B = Details
12/31/13 Q413 $0.21$0.13 +$0.08$1.84B$1.83B Details
10/24/13 Q313 $0.17$0.09 +$0.08$1.74B$1.73B = Details
7/25/13 Q213 $0.18$0.10 +$0.08$1.81B$1.78B = Details